Related Experiment Video
Updated: May 9, 2026

07:22
Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
Published on: April 11, 2025
Long-term oncologic outcomes of laparoscopic versus open partial nephrectomy
Jun-hua Zheng1, Xiao-long Zhang, Jiang Geng
1Department of Urology, Shanghai Tenth People's Hospital, Tongji University, Shanghai 200072, China. zhengjh0471@sina.com
Chinese Medical Journal
|August 9, 2013
Summary
This meta-analysis found no significant difference in long-term oncologic outcomes between laparoscopic partial nephrectomy (LPN) and open partial nephrectomy (OPN) for localized renal tumors. Both surgical approaches offer comparable survival and recurrence rates over five years.
Area of Science:
- Urology
- Surgical Oncology
- Nephrology
Background:
- Existing literature on partial nephrectomy primarily focuses on technical aspects and short-to-mid-term results.
- The long-term oncologic efficacy comparison between laparoscopic (LPN) and open (OPN) partial nephrectomy remains insufficiently explored.
- Localized renal tumors are often treated with nephron-sparing surgery, necessitating understanding of long-term outcomes.
Purpose of the Study:
- To conduct a meta-analysis comparing the long-term oncologic outcomes of LPN versus OPN for localized renal tumors.
- To clarify the long-term oncologic efficacy of LPN relative to OPN in renal tumor treatment.
Main Methods:
- A systematic literature search was performed across Medline, Embase, and Cochrane Library databases.
- Eligible studies included comparative trials reporting long-term oncologic outcomes for LPN and OPN.
- Oncologic outcomes were analyzed using odds ratios (OR) and 95% confidence intervals (CI); study quality was assessed using the Newcastle-Ottawa scale.
Main Results:
- Six comparative studies with 1495 participants (555 LPN, 940 OPN) were included.
- No statistically significant differences were observed in 5-year overall survival (OR = 1.83, 95% CI (0.80, 4.19)).
- Similarly, 5-year cancer-specific survival (OR = 1.09, 95% CI (0.62, 1.92)) and 5-year recurrence-free survival (OR = 0.68, 95% CI (0.37, 1.26)) showed no significant divergence between LPN and OPN.
Conclusions:
- This meta-analysis indicates that LPN and OPN yield comparable long-term oncologic outcomes for localized renal tumors.
- The findings suggest that LPN is a viable alternative to OPN regarding long-term cancer control.
